From: From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria
Hemolytic effects on RRx-001, Artemether, & RRx-001 + Artemether | |||
---|---|---|---|
Hematocrit, % | BL | Day 1 | Day 1 |
RRx-001 | 51 ± 2 | 49 ± 1 | 49 ± 2 |
Artemether | 51 ± 2 | 47 ± 2 | 48 ± 2 |
RRx-001 + Arthemether | 50 ± 2 | 46 ± 4 | 47 ± 2 |